DMAC vs EL · $157.4M cap vs rev $15.05B
DiaMedica Therapeutics Inc (DMAC) versus Estee Lauder Companies Inc (EL) — a side-by-side from cached financials, not a winner call.
DiaMedica Therapeutics Inc (DMAC) is a biotechnology company listed on US.
Estee Lauder Companies Inc (EL) is a household & personal products company listed on US.
DMAC does not have a complete income-statement cache yet.
Latest reported EL revenue for 2026-06-30 was $15.05B. Net income was $182.0M. Revenue was up 5.0% from 2025-06-30 to 2026-06-30. EL currently screens at market cap $31.92B.
DMAC currently screens at market cap $157.4M. EL currently screens at market cap $31.92B.
Not investment advice. Open the DMAC and EL stock pages for the full models.
Not investment advice.